Hydroxyacyl-coenzyme A dehydrogenase gene, an acyl-coenzyme A thiolase gene, genetically engineered strains and a use thereof

Patent metadata

Field	Value
Publication number	US-10351891-B2
Application number	US-201415535274-A
Country	US
Kind code	B2
Filing date	Dec 12, 2014
Priority date	Dec 12, 2014
Publication date	Jul 16, 2019
Grant date	Jul 16, 2019

Abstract

The present invention provides a hydroxyacyl-coenzyme A dehydrogenase gene, an acyl-coenzyme A thiolase gene, genetically engineered strains and a use thereof. The hydroxyacyl-coenzyme A dehydrogenase gene encodes a protein (i) or (ii) as follows: (i) having an amino acid sequence according to SEQ ID NO 2; (ii) derived by substituting, deleting or inserting one or more amino acids in the amino acid sequence defined by (i) and having the same function as that of the protein of (i). The present invention constructs genetically engineered Mycobacterium strains lacking of a hydroxyacyl-coenzyme A dehydrogenase gene or an acyl-coenzyme A thiolase gene, which are used in the preparation of steroidal compounds, such as 1,4-BNA, 4-BNA, 9-OH-BNA, etc. Further, the invention improves the production efficiency and product quality of steroidal drug, improves the utilization of drug precursors, reduces the production costs, and provides the advantages of mild reaction conditions, environmentally friendly, and high economic and social benefits.

First claim

What is claimed is:

1. A method of preparing steroidal compounds, comprising the steps of:
providing a Mycobacterium NwIB-00 having hydroxyacyl-coenzyme A dehydrogenase gene and acyl-coenzyme A thiolase gene,
said hydroxyacyl-coenzyme A dehydrogenase gene encodes a protein having an amino acid sequence according to SEQ ID NO 2, and said acyl-coenzyme A thiolase gene encodes a protein having an amino acid sequence according to SEQ ID NO 4; and
constructing six different genetically engineered Mycobacterium neoaurum strains NwIB-X01, NwIB-X02, NwIB-X03, NwIB-X04, NwIB-X05 and NwIB-X06 from the Mycobacterium NwIB-00 by the method of gene knockout, and
culturing the six different genetically engineered Mycobacterium neoaurum strains to transform and degrade sterol to produce the steroidal compounds as follows:
NwIB-X01 lacking hydroxyacyl-coenzyme A dehydrogenase gene (hsd4A) and 3-ketosteriod-9α-hydroxylase (kshA1) produces 1,4-BNA and 4-BNA;
NwIB-X02 lacking hsd4A and 3-ketosteroid-Δ 1 -dehydrogenase gene (kstd1) and kshA1 produces 1,4-BNA and 4-BNA;
NwIB-X03 lacking hsd4A and kshA1 and kstd1 and kstd2 and kstd3 produces 4-BNA and 9-OH-BNA;
NwIB-X04 lacking hsd4A and kstd1 produces 9-OH-BNA and 9-OH-AD;
NwIB-X05 lacking hsd4A and kstd1 and kstd2 and kstd3 produces 9-OH-BNA; and
NwIB-X06 lacking kshA1 and acyl-coenzyme A thiolase gene (fadA5) produces 1,4-BNA and 4-BNA.

Assignees

• Univ East China Science & Tech

Inventors

• Wang Fengqing
• Wei Dongzhi
• Xu Liqin
• Liu Haohao
• Liu Xinbin
• Chen Nenghui

Classifications

• C12Y101/01035

  3-Hydroxyacyl-CoA dehydrogenase (1.1.1.35) · CPC title

• C12N9/1029

  transferring groups other than amino-acyl groups (2.3.1) · CPC title

• C12N9/10

  Transferases (2.) (ribonucleases C12N9/22) · CPC title

• C12N9/0006 Primary

  acting on CH-OH groups as donors (1.1) · CPC title

• C12P33/00

  Preparation of steroids · CPC title